摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N3-[3-Methoxy-4-(5-oxazolyl)phenyl]-1-(3-nitrophenyl)-1H-1,2,4-triazole-3,5-diamine | 267645-10-3

中文名称
——
中文别名
——
英文名称
N3-[3-Methoxy-4-(5-oxazolyl)phenyl]-1-(3-nitrophenyl)-1H-1,2,4-triazole-3,5-diamine
英文别名
3-N-[3-methoxy-4-(1,3-oxazol-5-yl)phenyl]-1-(3-nitrophenyl)-1,2,4-triazole-3,5-diamine
N3-[3-Methoxy-4-(5-oxazolyl)phenyl]-1-(3-nitrophenyl)-1H-1,2,4-triazole-3,5-diamine化学式
CAS
267645-10-3
化学式
C18H15N7O4
mdl
——
分子量
393.362
InChiKey
OPDBFHCUSHADPB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    29
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    150
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • [EN] COMPOUNDS DERIVED FROM AN AMINE NUCLEUS THAT ARE INHIBITORS OF IMPDH ENZYME<br/>[FR] COMPOSES DERIVES D'UN NOYAU AMINE INHIBITEURS DE L'ENZYME IMPDH
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2000025780A1
    公开(公告)日:2000-05-11
    The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH mediated diseases, such as transplant rejection and autoimmune diseases.
    本发明揭示了IMPDH(鸟苷-5'-单磷酸脱氢酶)的新型抑制剂的鉴定。本文所披露的化合物和药物组合物对于治疗或预防IMPDH介导的疾病,如移植排斥和自身免疫疾病,是有用的。
  • EP1126843A4
    申请人:——
    公开号:EP1126843A4
    公开(公告)日:2005-06-15
  • COMPOUNDS DERIVED FROM AN AMINE NUCLEUS THAT ARE INHIBITORS OF IMPDH ENZYME
    申请人:BRISTOL-MYERS SQUIBB COMPANY
    公开号:EP1126843A1
    公开(公告)日:2001-08-29
  • Metabolism-modulating agents and uses therefor
    申请人:Whitehead Paul Jonathan
    公开号:US20060106097A1
    公开(公告)日:2006-05-18
    The present invention is directed to methods and agents for modulating adipogenesis. More particularly, the present invention relates to molecules that modulate the level or functional activity of inosine-5′ monophosphate dehydrogenase (IMPDH) and to their use in modulating the accumulation of lipids in adipocytes and/or the differentiation of preadipocytes to adipocytes for treating or preventing adiposity-related conditions including, but not limited to, obesity, lipoma, lipomatosis, cachexia or lipodystrophy or the loss of adipose tissue in trauma or atrophic conditions.
  • US7915255B2
    申请人:——
    公开号:US7915255B2
    公开(公告)日:2011-03-29
查看更多